PIP
MRK icon

Peachtree Investment Partners’s Merck MRK Stock Holding History

Peachtree Investment Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238K Sell
1,981
-8
-0.4% -$924 0.09% 85
2025
Q4 		$209K Sell
1,989
-1,622
-45% -$152K 0.07% 90
2025
Q3 		$303K Sell
3,611
-358
-9% -$29.5K 0.11% 72
2025
Q2 		$314K Hold
3,969
– – 0.12% 70
2025
Q1 		$356K Buy
3,969
+666
+20% +$62.2K 0.14% 64
2024
Q4 		$329K Sell
3,303
-326
-9% -$33.6K 0.12% 62
2024
Q3 		$412K Sell
3,629
-241
-6% -$28.6K 0.16% 55
2024
Q2 		$479K Sell
3,870
-386
-9% -$49.7K 0.19% 51
2024
Q1 		$562K Buy
4,256
+266
+7% +$32.8K 0.23% 43
2023
Q4 		$435K Sell
3,990
-1,085
-21% -$113K 0.18% 54
2023
Q3 		$522K Sell
5,075
-1,678
-25% -$181K 0.27% 42
2023
Q2 		$779K Sell
6,753
-1,183
-15% -$134K 0.36% 36
2023
Q1 		$844K Sell
7,936
-5,448
-41% -$588K 0.53% 31
2022
Q4 		$1.48M Buy
13,384
+9,683
+262% +$990K 0.91% 24
2022
Q3 		$319K Sell
3,701
-6,686
-64% -$597K 0.21% 50
2022
Q2 		$947K Buy
+10,387
New +$921K 0.59% 33

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Peachtree Investment Partners's MRK Position: Q1 2026 in Review

Peachtree Investment Partners reduced its Merck (MRK) stake by 0.4% in Q1 2026, selling an estimated $924 and leaving 1,981 shares worth $238K. The position accounts for 0.09% of the portfolio, ranked #85.

Peachtree Investment Partners first reported a position in MRK in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.48M in Q4 2022. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Peachtree Investment Partners held 1,981 shares of Merck worth $238K as of Q1 2026.
  • Peachtree Investment Partners sold 8 Merck shares in Q1 2026, an estimated $924.
  • Merck made up 0.09% of Peachtree Investment Partners's portfolio in Q1 2026, its #85 holding.
  • Peachtree Investment Partners first reported a position in Merck in Q2 2022 and has held it in 16 quarters since.
  • Peachtree Investment Partners's Merck position peaked at $1.48M in Q4 2022.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Peachtree Investment Partners's 13F filing for Q1 2026, filed 8 May 2026.